Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear. To assess congenital malformation rates associated with gestational age at initiat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA NETWORK OPEN 2021-06, Vol.4 (6), p.e2113180-e2113180
Hauptverfasser:	van Gerwen, Mathilde, Maggen, Charlotte, Cardonick, Elyce, Verwaaijen, Emma J, van den Heuvel-Eibrink, Marry, Shmakov, Roman G, Boere, Ingrid, Gziri, Mina M, Ottevanger, Petronella B, Lok, Christianne A R, Halaska, Michael, Shao, Long Ting, Struys, Ilana, van Dijk-Lokkart, Elisabeth M, Van Calsteren, Kristel, Fruscio, Robert, Zola, Paolo, Scarfone, Giovanna, Amant, Frédéric
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Drug-Induced - etiology Adolescent Adult Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use cancer Cancer therapies Chemotherapy Cohort Studies congenital malformation Drug Administration Schedule Female Fetal Development - drug effects Gestational Age Human health sciences Humans Medicin och hälsovetenskap Middle Aged Médecine de la reproduction (Gynécologie, andrologie, obstétrique) Neoplasms - drug therapy Odds Ratio Oncologie Oncology Online Only Original Investigation Pediatrics Pregnancy Pregnancy Trimester, First Pregnant Women Pédiatrie Reproductive medicine (gynecology, andrology, obstetrics) Sciences de la santé humaine Time Factors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!